ES2111492B1 - Derivados de 1-(2-(vinilo substituido))-3,4-dihidro-5h-2,3-benzodiazepina, procedimiento para su preparacion, composiciones farmaceuticas que los contienen y utilizacion de dichos derivados y composiciones para el tratamiento de trastornos del sistema nervioso central. - Google Patents
Derivados de 1-(2-(vinilo substituido))-3,4-dihidro-5h-2,3-benzodiazepina, procedimiento para su preparacion, composiciones farmaceuticas que los contienen y utilizacion de dichos derivados y composiciones para el tratamiento de trastornos del sistema nervioso central.Info
- Publication number
- ES2111492B1 ES2111492B1 ES09600303A ES9600303A ES2111492B1 ES 2111492 B1 ES2111492 B1 ES 2111492B1 ES 09600303 A ES09600303 A ES 09600303A ES 9600303 A ES9600303 A ES 9600303A ES 2111492 B1 ES2111492 B1 ES 2111492B1
- Authority
- ES
- Spain
- Prior art keywords
- derivatives
- alkyl
- compositions
- central nervous
- benzodiazepine
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Fee Related
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
- C07D405/02—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
- C07D405/06—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/55—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having seven-membered rings, e.g. azelastine, pentylenetetrazole
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D243/00—Heterocyclic compounds containing seven-membered rings having two nitrogen atoms as the only ring hetero atoms
- C07D243/02—Heterocyclic compounds containing seven-membered rings having two nitrogen atoms as the only ring hetero atoms having the nitrogen atoms in positions 1 and 2
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D491/00—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00
- C07D491/02—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00 in which the condensed system contains two hetero rings
- C07D491/04—Ortho-condensed systems
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D493/00—Heterocyclic compounds containing oxygen atoms as the only ring hetero atoms in the condensed system
- C07D493/02—Heterocyclic compounds containing oxygen atoms as the only ring hetero atoms in the condensed system in which the condensed system contains two hetero rings
- C07D493/04—Ortho-condensed systems
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Animal Behavior & Ethology (AREA)
- Life Sciences & Earth Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Medicinal Chemistry (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Neurosurgery (AREA)
- Neurology (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Biomedical Technology (AREA)
- Epidemiology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
Abstract
DERIVADOS DE 1-[2-VINILO SUBSTITUIDO)]-3,4-DIHIDRO-5H-2,3-BENZODIAZEPINA, PROCEDIMIENTO PARA SU PREPARACION, COMPOSICIONES FARMACEUTICAS QUE LOS CONTIENEN Y UTILIZACION DE DICHOS DERIVADOS Y COMPOSICIONES PARA EL TRATAMIENTO DE TRASTORNOS DEL SISTEMA NERVIOSO CENTRAL. LOS COMPUESTOS DE ACUERDO CON LA INVENCION CORRESPONDEN A LA FORMULA GENERAL (I). FORMULA DONDE R REPRESENTA HIDROGENO O ALCANOILO C1-4; R1 REPRESENTA FENILO QUE OPCIONALMENTE LLEVA 1-3 SUBSTITUYENTES IDENTICOS O DIFERENTES, SELECCIONADOS ENTRE EL GRUPO CONSISTENTE EN HALOGENO, NITRO, AMINO, (ALQUILO C1-4)AMINO, DI(ALQUILO C1-4)AMINO, (ALCANOILO C1-4)AMINO, ALQUILO C1-4, ALCOXI C1-4, METILENDIOXI E HIDROXI; O NAFTILO QUE OPCIONALMENTE LLEVA UN SUBSTITUYENTE SELECCIONADO ENTRE EL GRUPO CONSISTENTE EN HIDROXI, ALQUILO C1-4 Y ALCOXI C1-4; R2 REPRESENTA HIDROGENO O ALQUILO C1-4; R3 Y R4 SON, INDEPENDIENTEMENTE ENTRE SI, ALQUILO C1-4, O R3 Y R4 JUNTOS FORMAN METILENO. LOS NUEVOS COMPUESTOS DE ACUERDO CON LA INVENCION AFECTAN AL SISTEMA NERVIOSO CENTRAL Y SE PUEDEN UTILIZAR CON VENTAJA EN TERAPEUTICA.
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
HU9500386A HU224435B1 (hu) | 1995-02-09 | 1995-02-09 | Benzodiazepin-származékok, eljárás előállításukra, alkalmazásukra és ezeket tartalmazó gyógyászati készítmények |
Publications (2)
Publication Number | Publication Date |
---|---|
ES2111492A1 ES2111492A1 (es) | 1998-03-01 |
ES2111492B1 true ES2111492B1 (es) | 1999-07-01 |
Family
ID=10986432
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
ES09600303A Expired - Fee Related ES2111492B1 (es) | 1995-02-09 | 1996-02-08 | Derivados de 1-(2-(vinilo substituido))-3,4-dihidro-5h-2,3-benzodiazepina, procedimiento para su preparacion, composiciones farmaceuticas que los contienen y utilizacion de dichos derivados y composiciones para el tratamiento de trastornos del sistema nervioso central. |
Country Status (18)
Country | Link |
---|---|
US (1) | US6075018A (es) |
JP (1) | JP3354375B2 (es) |
KR (1) | KR960031444A (es) |
BE (1) | BE1009852A3 (es) |
CA (1) | CA2169112A1 (es) |
CZ (1) | CZ291218B6 (es) |
ES (1) | ES2111492B1 (es) |
FI (1) | FI960616A (es) |
FR (1) | FR2730490B1 (es) |
GB (1) | GB2297749B (es) |
HR (1) | HRP960065A2 (es) |
HU (1) | HU224435B1 (es) |
IT (1) | IT1282591B1 (es) |
PL (1) | PL312707A1 (es) |
RU (1) | RU2155757C2 (es) |
SK (1) | SK281482B6 (es) |
UA (1) | UA45954C2 (es) |
YU (1) | YU8396A (es) |
Families Citing this family (10)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US6649607B2 (en) * | 2001-05-18 | 2003-11-18 | Vela Pharmaceuticals, Inc. | Compositions and methods for treating or preventing convulsions or seizures |
JP2006514084A (ja) * | 2002-12-03 | 2006-04-27 | ヴェラ ファーマスーティカルズ インコーポレイテッド | 1−(3−ヒドロキシ−4−メトキシフェニル)−4−メチル−5−エチル−7,8−ジメトキシ−5h−2,3−ベンゾジアゼピンの製薬組成物及びその用途 |
US6638928B1 (en) | 2002-12-03 | 2003-10-28 | Vela Pharmaceuticals, Inc. | Treatment of irritable bowel syndrome and nonulcer dyspepsia with substituted 2,3-benzodiazepines |
EP1567161A4 (en) * | 2002-12-03 | 2008-09-03 | Vela Acquisition Corp | PHARMACEUTICAL COMPOSITION OF 1- (3,4-DIMETHOXYPHENYL) -4-METHYL-5-ETHYL-7-METHOXY-8-HYDROXY-5H-2,3-BENZODIAZEPINE AND ITS USE |
US7022700B2 (en) * | 2002-12-03 | 2006-04-04 | Vela Pharmaceuticals, Inc. | Method of increasing neutrophil production using optically-pure (R)-2,3-benzodiazepines |
US6864251B2 (en) * | 2002-12-03 | 2005-03-08 | Vela Pharmaceuticals, Inc. | Treatment of LTB4-mediated inflammatory disorders with optically-pure (R)-2,3-benzodiazepines |
US20040152694A1 (en) * | 2003-02-04 | 2004-08-05 | Istvan Kurucz | Methods and compositions for treating inflammatory disorders of the airways |
US20040224943A1 (en) * | 2003-02-19 | 2004-11-11 | Leventer Steven M. | Method of lowering body temperature with (R) - 2,3-benzodiazepines |
EP1833815B1 (en) * | 2004-12-30 | 2010-09-15 | Instytut Farmaceutyczny | A process for preparation of imatinib base |
EP2338492A1 (en) | 2009-12-24 | 2011-06-29 | Universidad del Pais Vasco | Methods and compositions for the treatment of alzheimer |
Family Cites Families (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
BE761315A (es) * | 1970-01-12 | 1971-07-07 | S M B Anciens Etablissements J | |
HU179018B (en) * | 1978-10-19 | 1982-08-28 | Gyogyszerkutato Intezet | Process for producing new 5h-2,3-benzodiazepine derivatives |
HU186760B (en) * | 1981-03-12 | 1985-09-30 | Gyogyszerkutato Intezet | Process for preparing 3,4-dihydro-5h-2,3-aenzodiazepine derivatives |
HU195788B (en) * | 1986-05-21 | 1988-07-28 | Gyogyszerkutato Intezet | Process for producing 1-/hydroxy-stiryl/-5h-2,3-benzobiazepines and pharmaceutical compositions containing them |
-
1995
- 1995-02-09 HU HU9500386A patent/HU224435B1/hu active IP Right Grant
-
1996
- 1996-02-07 SK SK168-96A patent/SK281482B6/sk unknown
- 1996-02-08 ES ES09600303A patent/ES2111492B1/es not_active Expired - Fee Related
- 1996-02-08 HR HRP9500386A patent/HRP960065A2/hr not_active Application Discontinuation
- 1996-02-08 BE BE9600110A patent/BE1009852A3/fr not_active IP Right Cessation
- 1996-02-08 CZ CZ1996377A patent/CZ291218B6/cs not_active IP Right Cessation
- 1996-02-08 PL PL96312707A patent/PL312707A1/xx unknown
- 1996-02-08 CA CA002169112A patent/CA2169112A1/en not_active Abandoned
- 1996-02-08 RU RU96102418/04A patent/RU2155757C2/ru active
- 1996-02-08 FR FR9601551A patent/FR2730490B1/fr not_active Expired - Fee Related
- 1996-02-08 UA UA96020483A patent/UA45954C2/uk unknown
- 1996-02-09 IT IT96MI000245A patent/IT1282591B1/it active IP Right Grant
- 1996-02-09 US US08/599,235 patent/US6075018A/en not_active Expired - Fee Related
- 1996-02-09 JP JP02396796A patent/JP3354375B2/ja not_active Expired - Fee Related
- 1996-02-09 GB GB9602690A patent/GB2297749B/en not_active Expired - Fee Related
- 1996-02-09 YU YU8396A patent/YU8396A/sh unknown
- 1996-02-09 KR KR1019960003129A patent/KR960031444A/ko not_active Application Discontinuation
- 1996-02-09 FI FI960616A patent/FI960616A/fi unknown
Also Published As
Publication number | Publication date |
---|---|
CZ37796A3 (en) | 1996-08-14 |
FR2730490B1 (fr) | 1997-04-18 |
US6075018A (en) | 2000-06-13 |
FI960616A (fi) | 1996-08-10 |
BE1009852A3 (fr) | 1997-10-07 |
JP3354375B2 (ja) | 2002-12-09 |
ES2111492A1 (es) | 1998-03-01 |
SK281482B6 (sk) | 2001-04-09 |
JPH08283247A (ja) | 1996-10-29 |
HRP960065A2 (en) | 1997-12-31 |
KR960031444A (ko) | 1996-09-17 |
GB2297749A (en) | 1996-08-14 |
PL312707A1 (en) | 1996-08-19 |
GB2297749B (en) | 1998-07-01 |
IT1282591B1 (it) | 1998-03-31 |
RU2155757C2 (ru) | 2000-09-10 |
CA2169112A1 (en) | 1996-08-10 |
GB9602690D0 (en) | 1996-04-10 |
UA45954C2 (uk) | 2002-05-15 |
ITMI960245A1 (it) | 1997-08-09 |
HU224435B1 (hu) | 2005-10-28 |
FR2730490A1 (fr) | 1996-08-14 |
ITMI960245A0 (es) | 1996-02-09 |
SK16896A3 (en) | 1996-10-02 |
YU8396A (sh) | 1998-12-23 |
HU9500386D0 (en) | 1995-03-28 |
FI960616A0 (fi) | 1996-02-09 |
CZ291218B6 (cs) | 2003-01-15 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
BR9712085A (pt) | Inibidores de metaloprotease heterocìclicos | |
MX9305379A (es) | Nuevos derivados de aminoacidos, procedimiento para su preparacion y preparado farmaceutico que los contiene. | |
ES2139959T3 (es) | Derivados de estilbeno utiles como inhibidores de la ciclooxigenasa-2. | |
PE20020720A1 (es) | Derivados benzimidazol y piridilimidazol como ligandos para receptores gabaa | |
FI842419A0 (fi) | 2-pyrimidinyl-1-piperazin-derivat, foerfarande foer deras framstaellning och dessa innehaollande laekemedel. | |
DK0687268T3 (da) | Spiroazacykliske derivater som substans P-antagonister | |
ES2164657T3 (es) | Derivados aza-biciclicos puenteados como antagonistas de la sustancia p. | |
ES2058527T3 (es) | Derivados de pirimidina condensados procedimiento y compuestos intermedios para su preparacion y composiciones farmaceuticas que los contienen. | |
DE69725608D1 (de) | Indolin-2-one derivate, verfahren zu ihrer herstellung und dieseenthaltende arzneimittel | |
MX9303263A (es) | Antagonistas de la angiotensina ii, procedimiento para su preparacion y formulaciones farmaceuticas que los contienen | |
ES2111492B1 (es) | Derivados de 1-(2-(vinilo substituido))-3,4-dihidro-5h-2,3-benzodiazepina, procedimiento para su preparacion, composiciones farmaceuticas que los contienen y utilizacion de dichos derivados y composiciones para el tratamiento de trastornos del sistema nervioso central. | |
AR035153A1 (es) | Derivados de carboxamidas y cetonas de dihidrobenzodioxina | |
AR013078A1 (es) | Derivados de tetrahidroisoquinoleina, una sal de los mismos, procedimiento para su preparacion, composicion farmaceutica que los comprende y el uso de losmismos en la preparacion de un medicamento. | |
AR015036A1 (es) | Derivados de indolilo antisicoticos, composicion farmaceutica que los contiene y su uso para la manufactura de un medicamento | |
AR008291A1 (es) | Derivados de tetrahidroisoquinolina, procedimiento para su preparacion, composiciones farmaceuticas que los contienen y su uso para la preparacionde un medicamento. | |
AR002711A1 (es) | Un compuesto de 2-carboxindol-3-substituido,un proceso para su preparacion, un nuevo compuesto intermediario para dicho proceso, el uso del compuesto parala fabricacion de un agente terapeutico y una composicion farmaceutica que comprende dicho compuesto. | |
ES2148858T3 (es) | (aminoalquil- y acilaminoalquil-oxi)benciloxiquinolinas, procedimiento para su preparacion y su empleo como antagonistas de receptores de bradiquinina. | |
ES2106936T5 (es) | Derivados de carbazolona y procedimientos para su preparacion. | |
IL65802A (en) | 1-(3-fluoro-2-pyridinyl)piperazine and salts thereof,their preparation and pharmaceutical compositions containing them | |
FI905957A0 (fi) | Foerfarande foer framstaellning av substituerade cyklohexener, som verkar pao det centrala nervsystemet. | |
KR960703401A (ko) | 약학적 활성을 갖는 피리다지논 유도체[pyridazinone derivatives with pharmaceutical activity] | |
ES2187783T3 (es) | Derivados de indolina utiles como antagonistas del receptor 5-ht-2c. | |
ES533938A0 (es) | Un procedimiento para la preparacion de nuevos derivados de isoindol | |
ES2144888T3 (es) | 4-(6-fluoro-(1h)-indol-3-il)-1,2,3,6-tetrahidropiridina sustituida para el tratamiento de desordenes del snc. | |
ES2111493B1 (es) | Derivados de 1-(2- (vinilo substituido ) ) -5h-2,3-benzo-diazepina, procedimiento para su preparacion, composiciones farmaceuticas que los contienen y utilizaciones correspondientes. |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
FC2A | Grant refused |
Effective date: 19971201 |
|
EC2A | Search report published |
Date of ref document: 19980301 Kind code of ref document: A1 Effective date: 19980301 |
|
FD2A | Announcement of lapse in spain |
Effective date: 20180806 |